Searchable abstracts of presentations at key conferences in endocrinology

ea0041oc4.3 | Thyroid - Clinical | ECE2016

Antibodies against human eye muscle tissue fractions bind to type 2 5’deiodinase and inhibit the lymphocyte MAPK activation derived from hyperthyroid patients with Graves’ disease

Molnar Ildiko , Szentmiklosi Jozsef A , Somogyine-Vari Eva

Type 2 5’-deiodinase (DIO2) is a common enzyme between thyroid and eye muscle tissues involving in T4 conversion to T3. The role of DIO2 has been demonstrated in the development of skeletal muscle. Increased DIO2 activities was connected to eye muscle enlargements in hyperthyroid Graves’ ophthalmopathy. In this study, the presence of antibodies against human eye muscle tissue fractions with the binding to DIO2 peptide was investigated and measur...

ea0056p1057 | Thyroid (non-cancer) | ECE2018

Antithyroid drugs can be associated with increased frequency of antibodies against type 2 5’-deiodinase enzyme influencing their therapeutical effectiveness in hyperthyroid Graves’ ophthalmopathy

Molnar Ildiko , Szentmiklosi Jozsef A , Gesztelyi Rudolf , Somogyine-Vari Eva

Antithyroid drugs represent mainly the first choice therapy in hyperthyroid Graves’ disease. Their therapeutical ineffectiveness can lead to the onset or the severity of ophthalmopathy associated with Graves’ disease. Type 2 5’-deiodinase enzyme (DIO2) plays a crucial role besides type 1 5’-deiodinase enzyme in the development of Graves’ hyperthyroidism. Anti-thyroid drugs inhibit the activity of both type 5’-deiodinases blocking the synthesis of ...